• - Tigecyclin Vergleichspräparat Risikodifferenz*
• + Tigecyclin Vergleichspräparat Risikodifferenz*
• - Tygacila n/N (%) Vancomycin/Aztreonamb n/N (%)
• + Tygacila n/N (%) Vancomycin/Aztreonamb n/N (%)
• - Tygacila n/N (%) Imipenem/Cilastatinb n/N (%)
• + Tygacila n/N (%) Imipenem/Cilastatinb n/N (%)
• -Pfizer PFE Switzerland GmbH, Zürich.
• +Pfizer AG, Zürich
• -LLD V011
• +LLD V013